您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定

Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)

摘要:

Background: Esophageal cancer is associated with substantial disease burden in China, and data on the economic burden are fundamental for setting priorities in cancer interventions. The medical expenditure for the diagnosis and treatment of esophageal cancer in China has not been fully quantified. This study aimed to examine the medical expenditure of Chinese patients with esophageal cancer and the associated trends. Methods: From 2012 to 2014, a hospital-based multicenter retrospective survey was conducted in 37 hospitals in 13 provinces/municipalities across China as a part of the Cancer Screening Program of Urban China. For each esophageal cancer patient diagnosed between 2002 and 2011, clinical information and expense data were extracted by using structured questionnaires. All expense data were reported in Chinese Yuan (CNY; 1 CNY= 0.155 USD) based on the 2011 value and inflated using the year-specific health care consumer price index for China. Results: A total of 14,967 esophageal cancer patients were included in the analysis. It was estimated that the overall average expenditure per patient was 38,666 CNY, and an average annual increase of 6.27% was observed from 2002 (25,111 CNY) to 2011 (46,124 CNY). The average expenditures were 34,460 CNY for stage Ⅰ, 39,302 CNY for stage Ⅱ, 40,353 CNY for stage Ⅲ, and 37,432 CNY for stage IV diseases (P < 0.01). The expenditure also differed by the therapy type, which was 38,492 CNY for surgery, 27,933 CNY for radiotherapy, and 27,805 CNY for chemotherapy (P < 0.05). Drugs contributed to 45.02% of the overall expenditure. Conclusions: These conservative estimates suggested that medical expenditures for esophageal cancer in China substantially increased in the last 10 years, treatment for early-stage esophageal cancer costs less than that for advanced cases, and spending on drugs continued to account for a considerable proportion of the overall expenditure.

更多
作者单位: Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou 450008, Henan, P. R. China;Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical Col-lege, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing 100021, P. R. China [1] Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical Col-lege, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing 100021, P. R. China [2] Department of Human Resources, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, Henan, P. R. China [3] Institute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou 730000, Gansu, P. R. China [4] Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences (CAMS), Beijing 100020, P. R. China [5] Hunan Office for Cancer Control and Research, Hunan Provincial Cancer Hospital, Changsha 410006, Hunan, P. R. China [6] Department of Health Economics, School of Health Management, Harbin Medical University, Harbin 150081, Heilongjiang, P. R. China [7] Center for Health Management and Policy, Key Lab of Health Economics and Policy, Shandong University, Jinan 250012, Shandong, P. R. China [8] Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical Col-lege, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing 100021, P. R. China;Institute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou 730000, Gansu, P. R. China [9] Institute of Chronic Non-Communicable Diseases Pre-vention and Control, Jiangsu Provincial Center for Disease Control and Preven-tion, Nanjing 210009, Jiangsu, P. R. China [10] Science and Education Depart-ment of Public Health Division, Shandong Tumor Hospital, Jinan 250117, Shandong, P. R. China [11] Chongqing Office for Cancer Control and Research, Chongqing Cancer Hospital, Chongqing 400030, P. R. China [12] Teaching and Research Department, Affiliated Cancer Hospital of Xinjiang Medical University, ürümqi 830011, Xinjiang, P. R. China [13] Cancer Epidemiology Research Center, Gansu Provincial Cancer Hospital, Lanzhou 730050, Gansu, P. R. China [14] Heilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University, Harbin 150081, Heilongjiang, P. R. China [15] Zhejiang Office for Cancer Control and Research, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang, P. R. China [16] Liaoning Office for Cancer Control and Research, Liaoning Cancer Hospital & Institute, Shenyang 110042, Liaoning, P. R. China [17] Department of Control and Prevention of Chronic Non-Communicable Diseases, Xuzhou Center for Disease Control and Preven-tion, Xuzhou 221006, Jiangsu, P. R. China [18] Ningbo Clinical Cancer Preven-tion Guidance Center, Ningbo NO. 2 Hospital, Ningbo 315010, Zhejiang, P. R. China [19] Department of Occupational Medicine, Tangshan People's Hospital, Tangshan 063001, Hebei, P. R. China [20] Health Department of Kailuan Group, Kailuan General Hospital, Tangshan 063000, Hebei, P. R. China [21] Department of Health Policy and Economic Research, Guangdong Provincial Institute of Public Health, Guangzhou 511430, Guangdong, P. R. China [22] Institute of Chronic Disease Prevention and Control, Harbin Center for Disease Control and Prevention, Harbin 150056, Heilongjiang, P. R. China [23] Urban Office of Cancer Early Detection and Treatment, Tieling Central Hospital, Tiel-ing 112000, Liaoning, P. R. China [24] Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou 450008, Henan, P. R. China [25]
期刊: 《癌症(英文版)》2017年36卷11期 548-559页 SCIEMEDLINEISTICCSCDBP
栏目名称: Original Article
DOI: 10.1186/s40880-017-0242-3
发布时间: 2018-01-25
  • 浏览:8
  • 下载:2

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!